Cargando…
Plasma exosome microRNAs are indicative of breast cancer
BACKGROUND: microRNAs are promising candidate breast cancer biomarkers due to their cancer-specific expression profiles. However, efforts to develop circulating breast cancer biomarkers are challenged by the heterogeneity of microRNAs in the blood. To overcome this challenge, we aimed to develop a m...
Autores principales: | Hannafon, Bethany N., Trigoso, Yvonne D., Calloway, Cameron L., Zhao, Y. Daniel, Lum, David H., Welm, Alana L., Zhao, Zhizhuang J., Blick, Kenneth E., Dooley, William C., Ding, W. Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016889/ https://www.ncbi.nlm.nih.gov/pubmed/27608715 http://dx.doi.org/10.1186/s13058-016-0753-x |
Ejemplares similares
-
Intercellular Communication by Exosome-Derived microRNAs in Cancer
por: Hannafon, Bethany N., et al.
Publicado: (2013) -
miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study
por: Hannafon, Bethany N., et al.
Publicado: (2019) -
Metastasis-associated protein 1 (MTA1) is transferred by exosomes and contributes to the regulation of hypoxia and estrogen signaling in breast cancer cells
por: Hannafon, Bethany N., et al.
Publicado: (2019) -
Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA)
por: Hannafon, Bethany N., et al.
Publicado: (2015) -
Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer
por: Xu, Yi-Fan, et al.
Publicado: (2017)